Title : An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice - Navab_2005_Arterioscler.Thromb.Vasc.Biol_25_1932 |
Author(s) : Navab M , Anantharamaiah GM , Reddy ST , Van Lenten BJ , Wagner AC , Hama S , Hough G , Bachini E , Garber DW , Mishra VK , Palgunachari MN , Fogelman AM |
Ref : Arterioscler Thromb Vasc Biol , 25 :1932 , 2005 |
Abstract : Navab_2005_Arterioscler.Thromb.Vasc.Biol_25_1932 |
ESTHER : Navab_2005_Arterioscler.Thromb.Vasc.Biol_25_1932 |
PubMedSearch : Navab_2005_Arterioscler.Thromb.Vasc.Biol_25_1932 |
PubMedID: 15961700 |
Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Wagner AC, Hama S, Hough G, Bachini E, Garber DW, Mishra VK, Palgunachari MN, Fogelman AM (2005)
An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice
Arterioscler Thromb Vasc Biol
25 :1932
Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Wagner AC, Hama S, Hough G, Bachini E, Garber DW, Mishra VK, Palgunachari MN, Fogelman AM (2005)
Arterioscler Thromb Vasc Biol
25 :1932